+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

mHealth Apps Market Size, Share & Trends Analysis Report By Type (Fitness, Lifestyle Management, Nutrition & Diet, Women's Health, Medication Adherence, Healthcare Providers/Payers), And Segment Forecasts, 2019 - 2026

  • ID: 4396364
  • Report
  • June 2019
  • Region: Global, Global
  • 80 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • GlaxoSmithKline PLC
  • Johnson and Johnson
  • Merck and Co.
  • MORE
The global mHealth apps market size is expected to reach USD 236.0 billion by 2026, according to this report. It is projected to expand at a CAGR of 44.7% during the forecast period. The market is majorly driven by increasing adoption of advanced technologies in healthcare facilities and the need to reduce long waiting periods to access healthcare facilities from specialists.Availability of mobile applications for users is witnessing a rapid growth, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. This increased role of patients coupled with the rising importance in staying updated and informed about their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Healthcare industry has been transitioning towards a value-based care model with mHealth becoming a widespread trend owing to the advent of technologies such as remote monitoring, electronic medical record, and other communication platforms. The increasing prevalence of disorders, such as diabetes, hypertension, cancer, and obesity along with the growing awareness about wellness and other preventive measures diseases among patients is expected to boost the mHealth market growth.

mHealth leverages from the 4Ps: personalized, predictive, participatory, and preventive measures for care delivery to provide optimal care to users. Moreover, rising penetration of smartphones, and other electronic devices, especially, in low- and middle-income countries and increasing focus on the use of mobile technology to manage care delivery is anticipated to benefit the market.

Further key findings from the report suggest:
  • Rapid growth in chronic diseases along with the rise in the number of app users is accountable for the mHealth apps market growth
  • The types of mHealth apps include fitness, lifestyle management, nutrition and diet, women’s health, medication adherence, healthcare providers, and disease management. Of these, the fitness category accounted for the majority of segment share in 2018
  • mHealth app vendors are focusing their attention on women's health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
  • Physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
  • North America led the mhealth applications market in 2018 in terms of revenue share pertaining to the technological advancements and presence of major players in the region
  • Some of the key players are Johnson & Johnson, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Merck and Co., Inc., Pfizer, and Sanofi

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • GlaxoSmithKline PLC
  • Johnson and Johnson
  • Merck and Co.
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 End Use
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 REGION
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Penetration Analysis
3.2.2 Market driver analysis
3.2.2.1 Increased prevalence of dental decay/infections
3.3 MHealth apps market: Business Environment Analysis Tools
3.3.1 Porter’s five forces analysis
3.3.2 PESTEL Analysis

Chapter 4 MHealth apps market: Type Analysis
4.1 MHealth apps Type Market Share Analysis, 2018 & 2026
4.2 MHealth apps Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
4.3.1 Fitness
4.3.1.1 Fitness market, 2015 - 2026 (USD Million)
4.3.2 Disease Management
4.3.2.1 Disease management market, 2015 - 2026 (USD Million)
4.3.3 Women’s Health
4.3.3.1 Women’s Health market, 2015 - 2026 (USD Million)
4.3.4 Lifestyle Management
4.3.4.1 Lifestyle management market, 2015 - 2026 (USD Million)
4.3.5 Nutrition & Diet
4.3.5.1 Nutrition & diet market, 2015 - 2026 (USD Million)
4.3.6 Healthcare Providers/Payers
4.3.6.1 Healthcare providers & payers market, 2015 - 2026 (USD Million)
4.3.7 Medication Adherence
4.3.7.1 Medication adherence market, 2015 - 2026 (USD Million)
4.3.8 Others
4.3.8.1 Others market, 2015 - 2026 (USD Million)

Chapter 5 mHealth apps market: Regional Analysis
5.1 MHealth apps Regional Market Share Analysis, 2018 & 2026
5.2 MHealth apps Regional Market: Segment Dashboard
5.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
5.4.1 North America
5.4.1.1 North America mHealth apps market, 2015 - 2026 (USD Million)
5.4.1.1.1 U.S.
5.4.1.1.1.1 U.S. mHealth apps market, 2015 - 2026 (USD Million)
5.4.1.1.2 Canada
5.4.1.1.2.1 Canada mHealth apps market, 2015 - 2026 (USD Million)
5.4.2 Europe
5.4.2.1 Europe mHealth apps market, 2015 - 2026 (USD Million)
5.4.2.1.1 U.K.
5.4.2.1.1.1 U.K. mHealth apps market, 2015 - 2026 (USD Million)
5.4.2.1.2 Germany
5.4.2.1.2.1 Germany mHealth apps market, 2015 - 2026 (USD Million)
5.4.2.1.3 France
5.4.2.1.3.1 France mHealth apps market, 2015 - 2026 (USD Million)
5.4.2.1.4 Italy
5.4.2.1.4.1 Italy mHealth apps market, 2015 - 2026 (USD Million)
5.4.2.1.5 Spain
5.4.2.1.5.1 Spain mHealth apps market, 2015 - 2026 (USD Million)
5.4.3 Asia Pacific
5.4.3.1 Asia Pacific mHealth apps market, 2015 - 2026 (USD Million)
5.4.3.1.1 Japan
5.4.3.1.1.1 Japan mHealth apps market, 2015 - 2026 (USD Million)
5.4.3.1.2 China
5.4.3.1.2.1 China mHealth apps market, 2015 - 2026 (USD Million)
5.4.3.1.3 India
5.4.3.1.3.1 India mHealth apps market, 2015 - 2026 (USD Million)
5.4.4 Latin America
5.4.4.1 Latin America mHealth apps market, 2015 - 2026 (USD Million)
5.4.4.1.1 Brazil
5.4.4.1.1.1 Brazil mHealth apps market, 2015 - 2026 (USD Million)
5.4.4.1.2 Mexico
5.4.4.1.2.1 Mexico mHealth apps market, 2015 - 2026 (USD Million)
5.4.5 Middle East and Africa (MEA)
5.4.5.1 MEA mHealth apps market, 2015 - 2026 (USD Million)
5.4.5.1.1 South Africa
5.4.5.1.1.1 South Africa mHealth apps market, 2015 - 2026 (USD Million)

Chapter 6 Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
6.3 Vendor Landscape
6.3.1 Strategy Mapping
6.4 Company Market Position Analysis
6.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, strategic Initiatives, employee strength)
6.5 Company Profiles
6.5.1 Abbott
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.1.5 SWOT analysis
6.5.2 Johnson and Johnson
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.2.5 SWOT analysis
6.5.3 AstraZeneca PLC
6.5.3.1 Company overview
6.5.3.2 Financial performance
6.5.3.3 Product benchmarking
6.5.3.4 Strategic initiatives
6.5.3.5 SWOT analysis
6.5.4 Roche
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.4.5 SWOT analysis
6.5.5 Novartis
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.5.5 SWOT analysis
6.5.6 Bristol-Myers Squibb
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.6.5 SWOT analysis
6.5.7 GlaxoSmithKline PLC
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
6.5.7.5 SWOT analysis
6.5.8 Merck and Co.
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.8.5 SWOT analysis
6.5.9 Pfizer
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.9.4 Strategic initiatives
6.5.9.5 SWOT analysis
6.5.10 Sanofi
6.5.10.1 Company overview
6.5.10.2 Financial performance
6.5.10.3 Product benchmarking
6.5.10.4 Strategic initiatives
6.5.10.5 SWOT analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott
  • Johnson and Johnson
  • AstraZeneca PLC
  • Roche
  • Novartis
  • Bristol-Myers Squibb
  • GlaxoSmithKline PLC
  • Merck and Co.
  • Pfizer
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll